- Home
- MLTX vs ESBA Comparison
MLTX vs ESBA Comparison
Compare MLTX & ESBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLTX
- ESBA
- Stock Information
- Founded
- MLTX 2021
- ESBA N/A
- Country
- MLTX Switzerland
- ESBA United States
- Employees
- MLTX N/A
- ESBA N/A
- Industry
- MLTX Biotechnology: Pharmaceutical Preparations
- ESBA
- Sector
- MLTX Health Care
- ESBA
- Exchange
- MLTX Nasdaq
- ESBA NYSE
- Market Cap
- MLTX 2.3B
- ESBA 2.2B
- IPO Year
- MLTX N/A
- ESBA 2013
- Fundamental
- Price
- MLTX $38.33
- ESBA N/A
- Analyst Decision
- MLTX Strong Buy
- ESBA
- Analyst Count
- MLTX 8
- ESBA 0
- Target Price
- MLTX $80.50
- ESBA N/A
- AVG Volume (30 Days)
- MLTX 489.2K
- ESBA 5.8K
- Earning Date
- MLTX 05-06-2025
- ESBA 01-01-0001
- Dividend Yield
- MLTX N/A
- ESBA 2.02%
- EPS Growth
- MLTX N/A
- ESBA N/A
- EPS
- MLTX N/A
- ESBA 0.28
- Revenue
- MLTX N/A
- ESBA $763,152,000.00
- Revenue This Year
- MLTX $103.42
- ESBA N/A
- Revenue Next Year
- MLTX N/A
- ESBA N/A
- P/E Ratio
- MLTX N/A
- ESBA $24.91
- Revenue Growth
- MLTX N/A
- ESBA 3.19
- 52 Week Low
- MLTX $31.42
- ESBA $6.39
- 52 Week High
- MLTX $58.26
- ESBA $11.50
- Technical
- Relative Strength Index (RSI)
- MLTX 51.82
- ESBA 35.45
- Support Level
- MLTX $31.90
- ESBA $6.70
- Resistance Level
- MLTX $37.73
- ESBA $7.07
- Average True Range (ATR)
- MLTX 2.99
- ESBA 0.27
- MACD
- MLTX 0.29
- ESBA 0.03
- Stochastic Oscillator
- MLTX 74.53
- ESBA 40.14
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
About ESBA EMPIRE STATE REALTY OP LIM PARTNER
Empire State Realty OP LP is an NYC-focused real estate investment trust (REIT) that owns and operates a portfolio of well-leased, top-of-tier, modernized, amenitized, and well-located office, retail, and multifamily assets, conducts all of its business and owns substantially all of its assets. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.